HSCI 305 Chapter Notes - Chapter week 9: Prescription Drug, Working Poor, Electronic Prescribing
24 Jan 2018
School
Department
Course
Professor
Document Summary
Addressing cost-related barriers to prescription drug use in canada, tang. Drug expenses are a barrier to appropriate therapy. Federal government established an independent body - patented medicine prices review board of canada. Regulates prices of pres and non-pres patented drugs to ensure that they are not excessive. With other medicines in the same therapeutic class have been sold in the relevant canadian market. The 7 oecd countries have generally high medication prices - 4 have highest prices worldwide. The board does not regulate prices of generic drugs. P/t governments have a direct influence on the provision of prescription drugs by. Wide variations in provincial drug plans across canada. Most p/t provide incentives to use generic drugs. Benefit plans reimburse only the cost of generic alternatives. If the brand-name drug is desired, then the patient must pay the difference. P/t have been actively trying to reduce generic drug prices. Ontario - no higher than 25% of the brand-name drug price.
